Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic arthritis, according to data published in Therapeutic Advances in Musculoskeletal ...

Treatment of psoriatic arthritis is aimed at relieving symptoms, reducing inflammation, and preventing damage to the joints.

You may need topical, oral, or systemic treatments. There are some things ... but here's the connection. Psoriasis and psoriatic arthritis are different diseases, but they are related.

As with the introduction of TNFi into routine practice, new biologic treatments will need to ... the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous ...

SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...

Some medications used to treat psoriatic arthritis can also potentially cause ... of these new symptoms and help you develop the best treatment plan. Healthline has strict sourcing guidelines ...

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, ...

Biologic treatments do not display difference in ... The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment ...